In our results, high CD8+ (and PD‐1+) immune cell infiltrations in the outer stroma were significant and independent favorable prognostic factors for OS and PFS in CRC patients who did not receive NCRT. The gene discussed is CD8A; the disease is colorectal carcinoma.